Similar articles

• Alzheimer disease: increased orexin level correlates with sleep disruption and cognitive decline in Alzheimer disease.

  Malkki H. Malkki H. Nat Rev Neurol. 2014 Dec;10(12):672. doi: 10.1038/nrneurol.2014.209. Epub 2014 Oct 28. Nat Rev Neurol. 2014. PMID: 25348006 No abstract available.
• Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease.

  Liguori C, Romigi A, Nuccetelli M, Zannino S, Sancesario G, Martorana A, Albanese M, Mercuri NB, Izzi F, Bernardini S, Nitti A, Sancesario GM, Sica F, Marciani MG, Placidi F. Liguori C, et al. JAMA Neurol. 2014 Dec;71(12):1498-505. doi: 10.1001/jamaneurol.2014.2510. JAMA Neurol. 2014. PMID: 25322206
• In Alzheimer disease, increased wake fragmentation found in those with lower hypocretin-1.

  Friedman LF, Zeitzer JM, Lin L, Hoff D, Mignot E, Peskind ER, Yesavage JA. Friedman LF, et al. Neurology. 2007 Mar 6;68(10):793-4. doi: 10.1212/01.wnl.0000256731.57544.f9. Neurology. 2007. PMID: 17339595 No abstract available.
• The physiological role of orexins.

  Martynska L, Wolinska-Witort E, Chmielowska M, Bik W, Baranowska B. Martynska L, et al. Neuro Endocrinol Lett. 2005 Aug;26(4):289-92. Neuro Endocrinol Lett. 2005. PMID: 16135995 Review.
• Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation.

  Beuckmann CT, Yanagisawa M. Beuckmann CT, et al. J Mol Med (Berl). 2002 Jun;80(6):329-42. doi: 10.1007/s00109-002-0322-x. Epub 2002 Apr 5. J Mol Med (Berl). 2002. PMID: 12072908 Review.